Graves’ hyperthyroidism treated with potassium iodide: early response and after 2 years of follow-up
Objective: As thionamide is associated with various adverse effects, we re-evaluated the practical efficacy of potassium iodide (KI) therapy for Graves’ hyperthyroidism (GD). Methods: We administered KI (mainly 100 mg/day) to 324 untreated GD patients and added methimazole (MMI) only to those rema...
Saved in:
| Main Authors: | Megumi Fujikawa, Ken Okamura |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bioscientifica
2024-11-01
|
| Series: | European Thyroid Journal |
| Subjects: | |
| Online Access: | https://etj.bioscientifica.com/view/journals/etj/13/6/ETJ-24-0085.xml |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A narrative review of long-term inorganic iodine monotherapy for Graves’ disease with a historical relationship between iodine and thyroid
by: Natsuko Watanabe
Published: (2025-01-01) -
Potassium Iodide in Dermatology- Recent Advances in Mechanism of Action, Preparation, Uses and Adverse Effects
by: Nishant Goel, et al.
Published: (2025-05-01) -
Therapeutic effectiveness of iodine-rich herbs in treating Graves’ hyperthyroidism: a retrospective cohort study from a single center
by: Yiwen Lai, et al.
Published: (2025-08-01) -
Diagnostic and Follow-up Characteristics of Cases Presenting with Hyperthyroidism in Childhood
by: Yasemin Denkboy Öngen, et al.
Published: (2025-08-01) -
Insight into the metabolic shifts in Graves' hyperthyroidism: a study of acylcarnitine and lipid profiles
by: Mikael Thomassen Neset, et al.
Published: (2025-06-01)